Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-704-5 | CAS number: 98-82-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
Description of key information
In the recent NTP evaluation (NTP 2009), cumene was tested in guideline studies for carcinogenicity in rats and mice. These studies were presented as robust study summaries in IUCLID Section 7.7.
Key value for chemical safety assessment
Justification for classification or non-classification
Based on the mode of action considerations (alpha-2u globulin and CYP2F2, CYP2F4 mediated cytotoxicity) there is no need for classification of cumene as carcinogenic Cat 1 or 2 in terms of EU classification. In addition, genotoxicity in vitro and in vivo was negative.
Additional information
CARCINOGENICITY IN EXPERIMENTAL ANIMALS
In the EU RAR (2001) no results were listed.
In the recent NTP evaluation (NTP 2009), cumene was tested in guideline studies for carcinogenicity in rats and mice. These studies were presented as robust study summaries in IUCLID Section 7.7.
RATS
Groups of 50 male and 50 female rats were exposed to cumene vapor at concentrations of 0, 250, 500, or 1,000 ppm, 6 hours plus T90 (12 minutes) per day, 5 days per week for 105 weeks. Survival of all exposed groups of rats was similar to that of the chamber controls. Mean body weights of 1,000 ppm females were slightly less than those of the chamber controls during the second year of the study but were similar to the chamber controls at the end of the study.
Incidences of adenoma of the respiratory epithelium in the nose occurred with a positive trend in males and were significantly increased in all exposed groups of males and in 250 ppm females. Incidences of hyperplasia of basal cells in the olfactory epithelium in the nose of all exposed groups and hyperplasia of the respiratory epithelium in the nose of all exposed groups of males and 1,000 ppm females were significantly increased.
The incidences of renal tubule adenoma in all exposed groups of males, renal tubule carcinoma in 500 and 1,000 ppm males, and renal tubule adenoma or carcinoma (combined) in all exposed groups of males were increased; the difference from chamber controls for the combined incidence was significant at 500 ppm. The incidences of hyperplasia of the renal tubule and transitional epithelium of the renal pelvis in 500 and 1,000 ppm males and mineralization of the renal papilla in all exposed groups of males were significantly greater than those of the chamber controls.
Based on criteria set by NTP it was concluded by the authors that cumene showed clear evidence of carcinogenicity based on adenoma of nose and adenoma or carcinoma of the kidney (male rats only).
The male rat kidney toxicity and resulting tumors fit the alpha-2u-globulin mode of action (MOA). This MOA does not occur in humans and, therefore, these tumors are not relevant for human risk assessment.
The effects observed in the respiratory epithelium are mediated by cytotoxicity and regenerative hyperplasia. The cytotoxicity is derived from species specific metabolic activation via CYP2F4 in rats.
Species differences observed between mouse and rat are likely contributed to different enzymatic metabolism by CYP2F2 in mouse and CYP2F4 in rat. The human CYP2F1 is much less prevalent in these tissues and is much less effective at metabolizing these compounds than either 2F2 or 2F4.
Therefore, this mode of action is of low relevance for humans and the relevance for human health risk assessment should be considered with care.
MICE
Groups of 50 male and 50 female mice were exposed to cumene vapor at concentrations of 0, 125 (female mice only), 250, 500, or 1000 (male mice only) ppm, 6 hours plus T90 (12 minutes) per day, 5 days per week for 105 weeks. An exposure concentration-related decrease in survival occurred in male mice, and the survival of 1000 ppm males was significantly less than that of the chamber controls. Mean body weights of 1000 ppm males were generally less than those of the chamber controls after week 8 of the study, and those of 500 ppm females were less from week 28 until week 76 of the study.
The incidences of alveolar/bronchiolar adenoma, alveolar/bronchiolar carcinoma, and alveolar/bronchiolar adenoma or carcinoma (combined) in all exposed groups of mice occurred with positive trends and were significantly greater than those in the chamber controls. The incidences of alveolar epithelial bronchiole metaplasia and bronchiole hyperplasia were significantly increased in all exposed groups of mice.
In female mice, the incidences of hepatocellular adenoma and hepatocellular adenoma or carcinoma (combined) occurred with positive trends and were significantly increased in the 500 ppm group. In male mice, there were significant increases in the incidences of eosinophilic foci of the liver.
In the nose, the incidences of olfactory epithelium atrophy, basal cell hyperplasia of the olfactory epithelium, atypical hyperplasia of the olfactory epithelium, hyperplasia of olfactory epithelium glands, and suppurative inflammation were generally significantly increased in 500 and 1,000 ppm males and 500 ppm females. The incidences of squamous metaplasia of the respiratory epithelium were significantly increased in 500 ppm females. The incidence of basal cell hyperplasia was also significantly increased in 250 ppm females.
Based on criteria set by NTP it was concluded by the authors that cumene showed clear evidence of carcinogenicity based on alveolar/bronchiolar adenoma and carcinoma of the lung.The effects observed in the lungs are mediated by cytotoxicity and regenerative hyperplasia. The cytotoxicity is derived from species specific metabolic activation via CYP2F2 in mice.
Species differences observed between mouse and rat are likely contributed to different enzymatic metabolism by CYP2F2 in mouse and CYP2F4 in rat. The human CYP2F1 is much less prevalent in these tissues and is much less effective at metabolizing these compounds than either 2F2 or 2F4.
Therefore, this mode of action is of low relevance for humans and the relevance for human health risk assessment should be considered with care.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.